Editorial: infliximab or adalimumab as first‐ or second‐line anti‐TNF—conflicting evidence. Issue 6 (23rd August 2021)
- Record Type:
- Journal Article
- Title:
- Editorial: infliximab or adalimumab as first‐ or second‐line anti‐TNF—conflicting evidence. Issue 6 (23rd August 2021)
- Main Title:
- Editorial: infliximab or adalimumab as first‐ or second‐line anti‐TNF—conflicting evidence
- Authors:
- Haydek, John P.
Scott, Frank I. - Abstract:
- LINKED CONTENT: This article is linked to Visuri et al papers. To view these articles, visit https://doi.org/10.1111/apt.16525 and https://doi.org/10.1111/apt.16569
- Is Part Of:
- Alimentary pharmacology & therapeutics. Volume 54:Issue 6(2021)
- Journal:
- Alimentary pharmacology & therapeutics
- Issue:
- Volume 54:Issue 6(2021)
- Issue Display:
- Volume 54, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 54
- Issue:
- 6
- Issue Sort Value:
- 2021-0054-0006-0000
- Page Start:
- 846
- Page End:
- 847
- Publication Date:
- 2021-08-23
- Subjects:
- Digestive organs -- Diseases -- Treatment -- Periodicals
Digestive organs -- Effect of drugs on -- Periodicals
Gastrointestinal system -- Diseases -- Treatment -- Periodicals
Gastrointestinal system -- Effect of drugs on -- Periodicals
615.73 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2036 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/apt.16555 ↗
- Languages:
- English
- ISSNs:
- 0269-2813
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0787.886000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18551.xml